Research progress of RhoGTPase activating protein in epithelial-mesenchymal transition

doi:10.16352/j.issn.1001-6325.2023.02.301

Abstract

Abstract: Epithelial-mesenchymal transition (EMT) is a process by which epithelial cells undergo morphological changes to gain a mesenchymal cell phenotype and migratory properties. As a class of negative regulators of RhoGTPases, RhoGTPase activating proteins(RhoGAP) can bridge between cell surface receptors and cellular actin cytoskeleton during EMT procedure, which may influence cancer cell transition and outcome of fibrotic diseases and may help search for anti-tumor and anti-fibrotic managements.

Key words: RhoGTPase activating protein, epithelial-mesenchymal transition, actin cytoskeleton, metastasis, fibrotic diseases

CLC Number:

XU Qian, DUAN Hua, GAN Lu, LIU Qiwei. Research progress of RhoGTPase activating protein in epithelial-mesenchymal transition[J]. Basic & Clinical Medicine, 2023, 43(2): 301-305.

References 24

[1]	Dalla PE, Forciniti S, Palmieri M, et al. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development[J]. Semin Cell Dev Biol,2018,78:62-72.
[2]	Kolb K, Hellinger J, Kansy M, et al. Influence of ARHGAP29 on the invasion of mesenchymal-transformed breast cancer cells[J]. Cells,2020,9.doi: 10.3390/cells9122616.
[3]	Correll KA, Edeen KE, Zemans RL, et al. Transitional human alveolar type Ⅱ epithelial cells suppress extracel-lular matrix and growth factor gene expression in lung fibroblasts[J]. Am J Physiol Lung Cell Mol Physiol,2019,317:L283-L294.
[4]	吴娜,王东,李京敏,等. 羟基红花黄色素A抑制人肝癌细胞系Huh7发生上皮-间质转化[J]. 基础医学与临床,2021,41:1423-1427.
[5]	Aspenstrom P. The intrinsic GDP/GTP exchange activities of Cdc42 and Rac1 are critical determinants for their specific effects on mobilization of the actin filament system[J]. Cells,2019,8. doi: 10.3390/cells8070759.
[6]	Svensmark JH, Brakebusch C. Rho GTPases in cancer: friend or foe?[J]. Oncogene,2019,38:7447-7456.
[7]	Lawson CD, Ridley AJ. Rho GTPase signaling complexes in cell migration and invasion[J]. J Cell Biol,2018,217:447-457.
[8]	Bagci H, Sriskandarajah N, Robert A, et al. Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms[J]. Nat Cell Biol,2020,22:120-134.
[9]	Pannekoek WJ, Vliem MJ, Bos JL. Multiple Rap1 effectors control Epac1-mediated tightening of endothelial junctions[J]. Small GTPases,2020,11:346-353.
[10]	Zhang K, Na T, Ge F, et al. DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-beta1 signaling[J]. Exp Cell Res,2020,386:111732. doi: 10.1016/j.yexcr.2019.111732.
[11]	Liu H, Liu Y, Sun P, et al. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression[J]. Clin Sci (Lond),2020,134:419-434.
[12]	Huang W, Liu J, Feng X, et al. DLC-1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR/Akt/NF-kappaB pathway[J]. Med Oncol,2015,32:115.doi: 10.1007/s12032-015-0564-4.
[13]	Ravi A, Kaushik S, Ravichandran A, et al. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) deleted in liver cancer 1 via focal adhesion kinase and protein phosphatase 2A[J]. J Biol Chem,2015,290:4149-4162.
[14]	Bidaud-Meynard A, Biname F, Lagree V, et al. Regula-tion of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP[J]. Small GTPases,2019,10:99-110.
[15]	Ouyang H, Luong P, Frodin M, et al. p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth[J]. Oncogene,2020,39:5570-5587.
[16]	Frank SR, Kollmann CP, Luong P, et al. p190 RhoGAP promotes contact inhibition in epithelial cells by repressing YAP activity[J]. J Cell Biol,2018,217:3183-3201.
[17]	Tian T, Chen ZH, Zheng Z, et al. Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis[J]. Theranostics, 2020, 10:5998-6010.
[18]	Hanley PJ, Vollmer V, Bahler M. Class Ⅸ myosins: motorized RhoGAP signaling molecules[J]. Adv Exp Med Biol,2020,1239:381-389.
[19]	Hemkemeyer SA, Vollmer V, Schwarz V, et al. Local Myo9b RhoGAP activity regulates cell motility[J]. J Biol Chem,2021,296: 100136. doi: 10.1074/jbc.RA120.013623.
[20]	Qian X, Hua D, Lu G, et al. MicroRNA-1291 promotes the endometrial fibrosis by regulating ArhGAP29-RhoA/ROCK1 signaling pathway in a murine model[J].Mol Med Rep, 2017, 16: 4501-4510.
[21]	李天柱,史铁伟,周静,等. 干扰ELK-3抑制人肝癌细胞的上皮-间质转换[J]. 基础医学与临床,2017,37:211-216.
[22]	Wang L, Shen S, Xiao H, et al. ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis[J]. Carcinogenesis,2020,41:711-721.
[23]	Chao H, Zhang M, Hou H, et al. HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p[J]. Life Sci,2020,243:117296.doi: 10.1016/j.lfs.2020.117296.
[24]	Brakebusch C. Rho GTPase signaling in health and disease: acomplex signaling network[J]. Cells,2021,10:401.doi: 10.3390/cells10020401.